Comparison of Second-Generation Stents for Application in the Superficial Femoral Artery: An In Vitro Evaluation Focusing on Stent Design

被引:35
作者
Mueller-Huelsbeck, Stefan [1 ]
Schaefer, Philipp J. [2 ]
Charalambous, Nikolas [2 ]
Yagi, Hiroshi [3 ]
Heller, Martin [2 ]
Jahnke, Thomas [2 ]
机构
[1] Ev Luth Diakonissenanstalt Flensburg, Dept Diagnost & Intervent Radiol Neuroradiol, Acad Hosp Flensburg, D-24939 Flensburg, Germany
[2] Univ Hosp Schleswig Holstein, Dept Radiol, Kiel, Germany
[3] Terumo, Tokyo, Japan
关键词
superficial femoral artery; stent; nitinol; experimental study; finite element analysis; stent design; fatigue testing; stent fracture; compression; bending; torsion; NITINOL STENT; IMPLANTATION; FRACTURES; LESIONS; QUANTIFICATION; ANGIOPLASTY; DISEASE; TRIAL;
D O I
10.1583/10-3069.1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: To examine and compare in an ex vivo study different nitinol stent designs intended for the superficial femoral artery (SFA) with regard to the appearance of fracture. Methods: Seven different 8-x40-mm nitinol stents were evaluated (Misago, Absolute, Smart, Luminexx, Sentinol, Lifestent NT, and Sinus-Superflex). Finite element analysis (FEA) was used for digitalized stent design comparison; the strain during stent movement was calculated for bending, compression, and torsion. Additional mechanical fatigue tests for bending (70 degrees), compression (40%), and torsion (twisted counterclockwise by 180 degrees) were performed up to 650,000 cycles or until a fracture was observed. Results:The FEA bending test showed that only the Misago, LifeStent, and Absolute stents presented no zones of high strain; in the torsion test, the Smart stent also had no zones of high strain. Macroscopic evaluation after mechanical bending indicated that the LifeStent performed the best (no stent fracture after 650,000 cycles). Misago and Absolute stents showed fractures at 536,000 cycles and 456,667 cycles, respectively (range 320,000-650,000 cycles). After compression and torsion testing, Misago showed no stent fracture after 650,000 cycles. The worst performing stent was Luminexx during all test cycles. Conclusion: The 7 SFA stents showed differences in the incidence of high strain zones, which indicates a potential for stent fracture, as demonstrated by the mechanical fatigue tests. Differences in stent design might play a major role in the appearance of stent strut fracture related to restenosis and reocclusion. J Endovasc Ther. 2010;17:767-776
引用
收藏
页码:767 / 776
页数:10
相关论文
共 16 条
[1]   Nitinol Stent Implantation in Long Superficial Femoral Artery Lesions: 12-Month Results of the DURABILITY I Study [J].
Bosiers, Marc ;
Torsello, Giovanni ;
Gissler, Hans-Martin ;
Ruef, Johannes ;
Mueller-Huelsbeck, Stefan ;
Jahnke, Thomas ;
Peeters, Patrick ;
Daenens, Kim ;
Lammer, Johannes ;
Schroe, Herman ;
Mathias, Klaus ;
Koppensteiner, Renate ;
Vermassen, Frank ;
Scheinert, Dierk .
JOURNAL OF ENDOVASCULAR THERAPY, 2009, 16 (03) :261-269
[2]   In Vivo Quantification of Femoral-Popliteal Compression During Isometric Thigh Contraction: Assessment Using MR Angiography [J].
Brown, Ryan ;
Nguyen, Thanh D. ;
Spincemaille, Pascal ;
Prince, Martin R. ;
Wang, Yi .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 29 (05) :1116-1124
[3]   The Effect of Aging on Deformations of the Superficial Femoral Artery Resulting from Hip and Knee Flexion: Potential Clinical Implications [J].
Cheng, Christopher P. ;
Choi, Gilwoo ;
Herfkens, Robert J. ;
Taylor, Charles A. .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2010, 21 (02) :195-202
[4]   In vivo MR angiographic quantification of axial and twisting deformations of the superficial femoral artery resulting from maximum hip and knee flexion [J].
Cheng, CP ;
Wilson, NM ;
Hallett, RL ;
Herfkens, RJ ;
Taylor, CA .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (06) :979-987
[5]  
DENSION A, 2004, P INT C SHAP MEM SUP, P95
[6]   Sirolimus-eluting versus bare nitinol Stent for obstructive superficial femoral artery disease:: The SIROCCO II trial [J].
Duda, SH ;
Bosiers, M ;
Lammer, J ;
Scheinert, D ;
Zeller, T ;
Tielbeek, A ;
Anderson, J ;
Wiesinger, B ;
Tepe, G ;
Lansky, A ;
Mudde, C ;
Tielemans, H ;
Bérégi, JP .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (03) :331-338
[7]   Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease [J].
Duda, SH ;
Pusich, B ;
Richter, G ;
Landwehr, P ;
Oliva, VL ;
Tielbeek, A ;
Wiesinger, B ;
Hak, JB ;
Tielemans, H ;
Ziemer, G ;
Cristea, E ;
Lansky, A ;
Bérégi, JP .
CIRCULATION, 2002, 106 (12) :1505-1509
[8]   Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions [J].
Grimm, J ;
Müller-Hülsbeck, S ;
Jahnke, T ;
Hilbert, C ;
Brossmann, J ;
Heller, M .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2001, 12 (08) :935-941
[9]   Standardized evaluation and reporting of Stent fractures in clinical trials of noncoronary devices [J].
Jaff, Michael ;
Dake, Michael ;
Pornpa, Jeffrey ;
Ansel, Gary ;
Yoder, Tony .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 70 (03) :460-462
[10]   Quantitative Assessment of the Conformational Change in the Femoropopliteal Artery with Leg Movement [J].
Klein, Andrew J. ;
Chen, S. James ;
Messenger, John C. ;
Hansgen, Adam R. ;
Plomondon, Mary E. ;
Carroll, John D. ;
Casserly, Ivan P. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 74 (05) :787-798